NEW YORK LIFE INVESTMENTS ET - NYLI FTSE INTERN (HFXI)

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / NYLI FTSE INTERN
Number of holders
57
Total 13F shares, excl. options
16,152,226
Shares change
+1,280,863
Total reported value, excl. options
$401,694,395
Value change
+$31,890,583
Number of buys
26
Number of sells
-18
Price
$24.87

Significant Holders of NEW YORK LIFE INVESTMENTS ET - NYLI FTSE INTERN (HFXI) as of Q4 2023

58 filings reported holding HFXI - NEW YORK LIFE INVESTMENTS ET - NYLI FTSE INTERN as of Q4 2023.
NEW YORK LIFE INVESTMENTS ET - NYLI FTSE INTERN (HFXI) has 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 16,152,226 shares .
Largest 10 shareholders include NEW YORK LIFE INVESTMENT MANAGEMENT LLC (4,637,369 shares), MORGAN STANLEY (2,507,217 shares), UBS Group AG (1,468,521 shares), AMERIPRISE FINANCIAL INC (1,001,611 shares), BANK OF AMERICA CORP /DE/ (822,307 shares), LPL Financial LLC (771,604 shares), Raymond James Financial Services Advisors, Inc. (637,840 shares), FLYNN ZITO CAPITAL MANAGEMENT, LLC (580,558 shares), WESPAC Advisors SoCal, LLC (516,830 shares), and RAYMOND JAMES & ASSOCIATES (335,975 shares).
This table shows the top 57 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.